Insulet Newsroom

Citi Maintains Insulet(PODD.US) With Buy Rating

Futu NewsJan 16 19:31

Bernstein Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $315

Futu NewsJan 15 19:33

Analysts Conflicted on These Healthcare Names: Elevance Health (ELV), Agilent (A) and Insulet (PODD)

TipRanksJan 15 19:13

Bernstein Adjusts Price Target on Insulet to $315 From $305, Keeps Outperform Rating

MT NewswiresJan 9 19:22

Bernstein Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $315

Futu NewsJan 9 07:32

Bernstein Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $305

Futu NewsJan 8 20:34

BofA Securities Maintains Insulet(PODD.US) With Buy Rating, Announces Target Price $305

Futu NewsJan 7 14:31

Insulet Is Maintained at Buy by TD Cowen

Dow JonesJan 3 23:48

Insulet Analyst Ratings

BenzingaJan 3 23:38

TD Cowen Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $324

Futu NewsJan 3 21:31

TD Cowen Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $324

Futu NewsJan 3 12:32

BTIG Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $300

Futu NewsDec 30, 2024 19:31

BTIG Raises Price Target on Insulet to $300 From $270, Maintains Buy Rating

MT NewswiresDec 30, 2024 19:26

Insulet Is Maintained at Overweight by JP Morgan

Dow JonesDec 13, 2024 03:47

Insulet Analyst Ratings

BenzingaDec 13, 2024 03:37

Nephron Research Adjusts Price Target on Insulet to $310 From $285

MT NewswiresDec 13, 2024 00:32

J.P. Morgan Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $330

Futu NewsDec 12, 2024 20:31

Morgan Stanley Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $317

Futu NewsDec 12, 2024 18:32

Insulet's Strong International Performance and Optimistic Type 2 Diabetes Market Outlook Drive Positive Analyst Rating

TipRanksDec 12, 2024 18:28

Citi Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $310

Futu NewsDec 11, 2024 20:31